5.1 Brevetto
 Distribuzione geografica
Continente #
NA - Nord America 8.097
EU - Europa 7.510
AS - Asia 4.458
SA - Sud America 183
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 45
OC - Oceania 9
Totale 20.364
Nazione #
US - Stati Uniti d'America 8.020
GB - Regno Unito 2.340
CN - Cina 2.114
IT - Italia 1.464
UA - Ucraina 882
SE - Svezia 835
SG - Singapore 796
JP - Giappone 664
TR - Turchia 489
DE - Germania 478
RU - Federazione Russa 289
FI - Finlandia 277
FR - Francia 267
VN - Vietnam 183
IE - Irlanda 163
BR - Brasile 140
AT - Austria 130
BE - Belgio 99
NL - Olanda 92
PL - Polonia 79
EU - Europa 61
IN - India 59
KR - Corea 55
CA - Canada 54
ES - Italia 29
AR - Argentina 22
RO - Romania 22
BD - Bangladesh 21
MX - Messico 16
KE - Kenya 13
ZA - Sudafrica 13
HK - Hong Kong 12
LT - Lituania 11
PT - Portogallo 10
CH - Svizzera 9
IQ - Iraq 8
AU - Australia 7
ID - Indonesia 7
MA - Marocco 7
PK - Pakistan 7
TG - Togo 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
IR - Iran 5
AL - Albania 4
EE - Estonia 4
IL - Israele 4
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
KG - Kirghizistan 3
PE - Perù 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BS - Bahamas 1
CY - Cipro 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PR - Porto Rico 1
SI - Slovenia 1
SL - Sierra Leone 1
SM - San Marino 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 20.364
Città #
Southend 2.184
Dallas 1.910
Chandler 823
Jacksonville 682
Ann Arbor 650
Ashburn 517
Nanjing 491
Houston 388
Izmir 364
Woodbridge 362
Singapore 344
Urbino 333
Beijing 323
Boardman 175
Nanchang 174
Munich 165
Dublin 150
Wilmington 148
New York 140
Düsseldorf 136
Vienna 128
San Mateo 122
Helsinki 108
Dong Ket 106
Princeton 103
Des Moines 99
Brussels 97
Los Angeles 92
Orciano Di Pesaro 92
Kunming 90
Cambridge 83
Jiaxing 74
Amsterdam 71
Shenyang 69
Tianjin 69
Fairfield 67
Hebei 65
Istanbul 65
Changsha 62
Moscow 60
Velikiy Novgorod 57
Seongnam 52
Milan 51
Kraków 50
Shanghai 44
Santa Clara 42
Hangzhou 39
Bremen 36
Lanzhou 33
Rome 33
Jinan 31
Paris 31
Seattle 30
Ho Chi Minh City 29
Venice 28
Ancona 27
Wuppertal 26
Buffalo 25
Council Bluffs 25
Toronto 24
Changchun 23
Turku 23
Warsaw 23
Hanoi 22
San Francisco 22
Tokyo 22
Dearborn 20
Guangzhou 20
Stockholm 20
Civitanova Marche 18
West Jordan 18
Montreal 17
Brooklyn 16
Frankfurt am Main 16
Ningbo 16
Zhengzhou 16
Atlanta 15
Bologna 15
Chicago 15
Florence 15
Denver 14
London 14
Poplar 14
Redwood City 14
Boston 13
Dormagen 12
Manchester 12
Nuremberg 12
Orem 12
Phoenix 12
Johannesburg 11
Macerata 11
Taranto 11
Ankara 10
Auburn Hills 10
Orange 10
Parma 10
São Paulo 10
Augusta 9
Chennai 9
Totale 13.496
Nome #
1,5-BENZODIAZEPINE-2,4-DIONE GASTRIN AND CHOLECYSTOKININ-B-RECEPTOR ANTAGONISTS 1.257
1,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(3H)-ONE DERIVATIVES, AND THEIR USE AS ANTICONVULSANT AND ANTIANXIETY AGENTS 1.252
Derivative of [(3-hydroxy-4-pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs 338
Device and single-molecule analysis method by means of detection of the collisions of a target molecule on functionalized nanopores 305
DEVICE FOR EMULATING ENERGY SOURCES USED TO POWER EMBEDDED SYSTEMS/DEVICES 296
Metodo di sintesi di derivati del glutatione [Method for the synthesis of glutathione derivatives] 277
Pharmaceutical composition of [(3-​hydroxy-​4 -​pyron-​2-​yl) methyl] -​amine derivatives and DNA demethylating agents and their use as anti-​neoplastic drugs 268
Microfluidic-formulated leukosome compositions and fabrication methods therefor 265
METHOD FOR PRODUCING OPTICALLY ACTIVE 1,2-DIAMINE COMPOUND AND OPTICALLY ACTIVE NIOBIUM CATALYST 239
10-(1-HYDROXYMETHYL)-11-OXO-1-AZATRICYCLOUNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS USEFUL AS ANTIBACTERIAL AND PROCESS FOR THEIR PREPARATION 236
2,4,5-TRISUBSTITUTED OXAZOLES 235
SULODEXIDE FOR USE IN THE TREATMENT OF PATHOLOGIES WHEREIN METALLOPROTEINASES ARE INVOLVED 228
Pharmaceutical composition or composition package containing a pyrimidine nucleoside analog and a purine nucleoside analog 227
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell'aria 227
Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment 226
Drug delivery systems 225
Modulation of Anxiety Through Blockade of Anandamide Hydrolysis 222
"Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions" 218
Corpo cavo di Sonda geotermica e Sonda geotermica 217
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 215
Uso del Sulodexide per la riduzione delle metalloproteasi di matrice 213
5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors, preparation, and therapeutic use.. 211
Attrezzo ginnico sportivo 211
Acyclovir prodrug and its use in pharmaceutical compositions 211
TEICOPLANIN HYDRAZIDES AS ANTIBACTERIALS 208
Processo per la preparazione di esteri degli acidi 2-aril-alcanoici 208
Control system of acoustic echo cancellers for telephone terminals with handset or handsfree 207
3,6-DISUBSTITUTED TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES 206
Method And Relative Test Structure For Measuring The Coupling Capacitance Between Two Interconnect Lines 206
Delivery of Contrasting Agents for Magnetic Resonance Imaging 199
Peripherally Restricted FAAH Inhibitors 199
Procedimento perfezionato per la riduzione di composti organici mediante l'impiego di idruro di magnesio 198
Biomimetic proteolipid vesicle compositions and uses thereof 195
Filtro per l’equalizzazione e/o la Linearizzazione sistemi non lineari 191
A process for the preparation of monosialoganglioside by autolysis of cattle brain. 191
Procedimento per la preparazione di monosialoganglioside 189
Production of triterpenic acids by in vitro culture of calluses deriving from the pulp of red sentinel apples 189
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 188
Pharmaceutical composition for the parenteral administration of melatonin, and a process for its preparation 188
Apparecchiatura per misurare la quantità di idrocarburi volatili presenti nell’aria 186
Procedimento per la preparazione di biopolimeri 183
DEVICE FOR GENERATING MICRO- AND NANO-FLOW MOBILE PHASE GRADIENTS FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 182
Procedimento per ottenere una sostanza antiossidante da peci fenoliche. 179
“Tretamerous derivative of indole-3-carbinol with anticancer activity and method of synthesis of said derivative “ 177
AMINOPYRROLE DERIVATIVES 176
5-fluorocitosina come agente antibatterico 176
Nanoparticles for delivery of a pharmacologically active agent 175
Nutritional supplement, especially for dairy products, comprises leptin. 175
Procedimento per la produzione di esteri metilici di acidi grassi per reazione di trigliceridi di origine naturale con alcol metilico in presenza di resine 174
Use of microparticles for antigen delivery 172
DERIVATIVES OF [(3-HYDROXY-4-PYRON-2-YL)-METHYL]-AMINE AND USE THEREOF AS ANTI-NEOPLASTIC DRUGS 171
5-fluorocitosina come agente antibatterico 169
Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments 168
Derivati 2-Acilamminoalchilindolici come Antagonisti/Agonisti Parziali della Melatonina 167
Transformed erythrocytes, process for preparing the same, and their use in pharmaceutical compositions” PCT/EP 92/01291 166
Preparation of glutathione derivatives as antiviral agents 164
DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS. 162
PYRROLO[3,4-d]PYRIMIDINES 161
A process for obtaining chemically defined and reproducible polydeoxyribonucleotides. 160
Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor ant their use as medicaments 160
ANTIINFLAMMATORY OXAZOLES 159
DERIVATI DI [(3-IDROSSI-4-PIRON-2-IL)METIL]-AMINA E LORO USO COME FARMACI ANTI-NEOPLASTICI 155
PYRROLO[3,4-d]PYRIMIDINES 153
“ ,Processo de producao de antioxidante alquilado, obtido a partir de fenois, cresois e preferencialmente do cardanol hidrogenado, 3-pentadecilfenol (3-PDP) aplicavel como aditivo em combustiveis e lubrificantes. “ 152
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 151
3,7-DIHYDROPYRROLO[3,4-e][1,4]DIAZEPIN-2(1H)-ONE DERIVATIVES 150
Derivati 1-Acilamminoalchilindolici come agonisti della melatonina. 148
PREPARATION AND TESTING OF N15-ALKYL AND N15,N15-DIALKYL DERIVATIVES OF TEICOPLANIN COMPOUNDS AS BACTERICIDES 148
3-AMINO-4-CARBAMYLPYRROLE DERIVATIVES 147
PROCEDIMENTO DI SELEZIONE AUTOMATICA DI FOTOGRAFIE DIGITALI DA UN ARCHIVIO PER LA CREAZIONE AUTOMATICA DI UNA SEQUENZA DI FOTO CHE RAPPRESENTA UNA STORIA EMOZIONALE DA STAMPARE E/O CONSERVARE 146
PHARMACOLOGICALLY ACTIVE PYRROLODIAZEPINES 145
Procedimento di valutazione automatica della qualità di foto digitali 145
Procedimento per la produzione di derivati t-butilati del cardanolo e del 3-n-pentadecilfenolo 144
Nanosfere polimeriche e relativo utilizzo per veicolare oligonucleotidi. 144
USE OF ISOLATED MATURE ADIPOCYTES IN REGENERATIVE MEDICINE FOR THE RECONSTRUCTION AND REPARATION OF TISSUES 144
PREPARATION OF 3-UREIDO-2,4-DIOXOTETRAHYDRO-1,5-BENZODIAZEPINES AS CCK AND GASTRIN ANTAGONISTS 143
Derivati fosforilati del cardanolo o del 3-n-pentadecilfenolo utili come additivi per lubrificanti e procedimento per la loro preparazione. 143
Derivato tetramerico dell'indol-3-carbinolo ad attività anticancerogena e metodo di sintesi del derivato stesso 142
PYRROLODIAZEPINES 142
AMINOPYRROLE DERIVATIVES 140
PYRROLO[3,4-b]PYRIDINES 139
PREPARATION OF 13-DE(ACETAMIDOGLUPYRANOSYL)-34-DEOXYTEICOPLANIN DERIVATIVES AS ANTIBACTERIALS 136
PYRROLODIAZEPINE DERIVATIVES 134
Composition and Methods of Inhibiting N-Acylethanolamine-hydrolyzing Acid Amidase 133
Nuovo procedimento per la raffinazione dell'olio derivato dai gusci delle noci di anacardio e prodotto ottenuto con tale procedimento. 131
MACCHINA PER ANALISI CHIMICA COMPRENDENTE LA COMBINAZIONE DELLA SPETTROMETRIA DI MASSA A IONIZZAZIONE ELETTRONICA CON LA CROMATOGRAFIA LIQUIDA 130
Methods, Compositions, and Other Compounds for Modulation of Monoacylglycerol Lipase Pain, and Stress-related Disorders 129
Preparation of 2-trichloroacetoxy-3,4,5,6-tetrachlorobenzoic acid and compositions containing same for treating benign mammalian neoformations. 127
PREPARATION OF DE(ACETYLGLUCOSAMINYL)DIDEHYDRODEOXYTEICOPLANIN DERIVATIVES AS ANTIBIOTICS 126
Procedimento per la produzione di antiossidanti solforati da derivati dell'olio del guscio della noce di anacardio. 125
ANTIINFLAMMATORY 4,5-OXAZOLEDICARBOXAMIDES 124
Manufacture of antioxidants for rubbers from phenolic pitch. 122
Derivati del glutatione e loro utilizzi per il trattamento di malattie virali 121
Procedimento per la preparazione di derivati perfluorurati del cardanolo utili come intermedi organici, idrorepellenti, impregnanti, insetticidi, fitofarmaci e precursori di bisfenoli, resine fenoliche o resine fenoliche modificate. 120
null 118
Inhibitors of anandamide transport and their therapeutic use 115
Filter for the equalization and/or linearization of non-Linear systems 114
Preparation and anticancer activity of tetramerous deriv. of indole-3-carbinol. 114
PREPARATION OF 22-DECHLOROTEICOPLANIN AS ANTIBACTERIALS 113
PREPARATION OF ANELLATED CARBAPENEMS AS ANTIBIOTICS 109
Totale 19.805


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.217 0 0 0 0 0 115 57 127 245 202 234 237
2021/20221.190 100 109 146 244 29 8 34 59 88 44 13 316
2022/20232.093 253 177 137 225 152 482 8 173 266 45 123 52
2023/2024625 56 62 29 51 41 152 39 65 3 35 17 75
2024/20251.768 152 64 434 117 49 112 151 108 180 97 193 111
2025/20263.961 390 851 1.565 623 338 194 0 0 0 0 0 0
Totale 20.462